Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus

Lupus

Volumn 23, Issue 4, 2014, Pages 353-359

  Martinez Ramos R ^a   Garcia Lozano J R ^a   Lucena, J M ^a   Castillo Palma, M J ^a   Garcia Hernandez F ^a   Rodriguez M C ^a   Nunez Roldan A ^a   Gonzalez Escribano M F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

asymptomatic phase; microRNA; Systemic lupus erythematosus (SLE)

Indexed keywords

MICRORNA; MICRORNA 10A; MICRORNA 143; MICRORNA 224; MICRORNA 31; MICRORNA 345; MICRORNA 576 5P; UNCLASSIFIED DRUG; CD19 ANTIGEN;

ADULT; ARTICLE; ASSAY; ASYMPTOMATIC DISEASE; CD19+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL POPULATION; COHORT ANALYSIS; CONTROLLED STUDY; DONOR; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VALIDATION PROCESS; CASE CONTROL STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PROCEDURES; VALIDATION STUDY;

ADULT; ANTIGENS, CD19; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84896120823     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314522335     Document Type: Article

References (41)

1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
2. Castro J, Balada E, Ordi-Ros J, et al. The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev. 2008 ; 7: 345-351
3. Tsuchiya N, Kyogoku C, Miyashita R, et al. Diversity of human immune system multigene families and its implication in the genetic background of rheumatic diseases. Curr Med Chem. 2007 ; 14: 431-439
4. Mitoma H, Horiuchi T, Kimoto Y, et al. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus. Int J Mol Med. 2005 ; 16: 609-615
5. Marks SD, Tullus K. Autoantibodies in systemic lupus erythematosus. Pediatr Nephrol. 2012 ; 27: 1855-1868
6. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986 ; 136: 2348-2357
7. Akahoshi M, Nakashima H, Tanaka Y, et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 1999 ; 42: 1644-1648
8. Hagiwara E, Gourley MF, Lee S, et al. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum. 1996 ; 39: 379-385
9. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004 ; 116: 281-297
10. Baek D, Villen J, Shin C, et al. The impact of microRNAs on protein output. Nature. 2008 ; 455: 64-71
11. Sethi A, Kulkarni N, Sonar S, et al. Role of miRNAs in CD4 T cell plasticity during inflammation and tolerance. Front Genet. Epub doi 10.3389/jgene 2013.00008. Collection 2013.
12. Gracias DT, Katsikis PD. MicroRNAs: Key components of immune regulation. Adv Exp Med Biol. 2011 ; 780: 15-26
13. Stanczyk J, Pedrioli DM, Brentano F, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008 ; 58: 1001-1009
14. Belver L, de Yébenes VG, Ramiro AR. MicroRNAs prevent the generation of autoreactive antibodies. Immunity. 2010 ; 33: 713-722
15. Fan W, Liang D, Tang Y, et al. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. 2012 ; 64: 3715-3725
16. Amarilyo G, La Cava A. miRNA in systemic lupus erythematosus. Clin Immunol. 2012 ; 144: 26-31
17. Tang Y, Luo X, Cui H, et al. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009 ; 60: 1065-1075
18. Ding S, Liang Y, Zhao M, et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 2012 ; 64: 2953-2963
19. Dai Y, Huang YS, Tang M, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus. 2007 ; 16: 939-946
20. Miao CG, Yang YY, He X, et al. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell Signal. 2013 ; 25: 1828-1836
21. Lu MC, Lai NS, Chen HC, et al. Decreased microRNA(miR)-145 and increased hsa-miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin Exp Immunol. 2013 ; 171: 91-99
22. Stagakis E, Bertsias G, Verginis P, et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis. 2011 ; 70: 1496-1506
23. Allantaz F, Cheng DT, Bergauer T, et al. Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One 2012. Epub; doi: 10.1371/journal.pone.0029979.
24. Kamatani A, Nakagawa Y, Akao Y, et al. Downregulation of anti-oncomirs hsa-miR-143/145 cluster occurs before APC gene aberration in the development of colorectal tumors. Med Mol Morphol 2013; 46: 166-171.
25. Tang JT, Wang JL, Du W, et al. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis. 2011 ; 32: 1207-1215
26. Zhi F, Cao X, Xie X, et al. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS One 2013; doi: 10.137/journal.pone. 0056718.
27. Wang Y, Toh HC, Chow P, et al. MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB J. 2012 ; 26: 3032-3041
28. Biswas PS, Gupta S, Stirzaker RA, et al. Dual regulation of IRF4 function in T and B cells is required for the coordination of T-B cell interactions and the prevention of autoimmunity. J Exp Med. 2012 ; 209: 581-596
29. Nagafuchi S, Katsuta H, Koyanagi-Katsuta R, et al. Autoimmune regulator (AIRE) gene is expressed in human activated CD4+ T-cells and regulated by mitogen-activated protein kinase pathway. Microbiol Immunol. 2006 ; 50: 979-987
30. Secchiero P, Corallini F, Barbarotto E, et al. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells. Cell Physiol. 2006 ; 207: 158-164
31. Wang H, Morse HC 3rd. IRF8 regulates myeloid and B lymphoid lineage diversification. Immunol Res. 2009 ; 43: 109-117
32. Biswas PS, Gupta S, Stirzaker RA, et al. Dual regulation of IRF4 function in T and B cells is required for the coordination of T-B cell interactions and the prevention of autoimmunity. J Exp Med. 2012 ; 209: 581-596
33. Sandling JK, Garnier S, Sigurdsson S, et al. A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Eur J Hum Genet. 2011 ; 19: 479-484
34. Lessard CJ, Adrianto I, Ice JA, et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet. 2012 ; 90: 648-660
35. Smith CJ, Oscarson M, Rönnblom L, et al. TSGA10 - a target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus. Scand J Immunol. 2011 ; 73: 147-153
36. Xu WD, Pan HF, Ye DQ, et al. Targeting IRF4 in autoimmune diseases. Autoimmun Rev. 2012 ; 11: 918-924
37. Macedo C, Evangelista AF, Marques MM, et al. Autoimmune regulator (Aire) controls the expression of microRNAs in medullary thymic epithelial cells. Immunobiology. 2013 ; 218: 554-560
38. Holcombe RF, Baethge BA, Wolf RE, et al. Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus. Lupus. 1994 ; 3: 97-102
39. Lit LC, Wong CK, Tam LS, et al. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis. 2006 ; 65: 209-215
40. Hrycek E, Franek A, Błaszczak E, et al. Serum levels of selected chemokines in systemic lupus erythematosus patients. Rheumatol Int. 2013 ; 34: 251-254
41. Salloum R, Niewold TB. Interferon regulatory factors in human lupus pathogenesis. Transl Res. 2011 ; 157: 326-331